First author [Ref.] | ICS | Placebo | Rate ratio of exacerbation | p-value | |||
Subjects n | Withdrawal % | Subjects n | Withdrawal % | Prior ICS use % | |||
Vestbo 18 | 145 | 25 | 145 | 35 | 0 | 0.96 | 0.736# |
Burge 19 | 372 | 43 | 370 | 53 | 57 | 0.75 | 0.026 |
Szafranski 6 | 198 | 31 | 205 | 44 | 26 | 0.85 | 0.224 |
Calverley 20 | 374 | 29 | 361 | 39 | 52 | 0.81 | 0.003 |
Calverley 7 | 257 | 40 | 256 | 41 | 46 | 0.89 | 0.308 |
Calverley 1 | 1534 | 38 | 1524 | 44 | 51 | 0.82 | 0.001 |
#: not reported in the paper; computed from a comparison of two Poisson counts.